Exact Mass: 200.123479
Exact Mass Matches: 200.123479
Found 500 metabolites which its exact mass value is equals to given mass value 200.123479,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Medetomidine
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Dexmedetomidine ((+)-Medetomidine) is a potent, selective and orally active agonist of α2-adrenoceptor, with a Ki of 1.08 nM. Dexmedetomidine shows 1620-fold selectivity against α1-adrenoceptor. Dexmedetomidine exhibits anxiolysis, sedation, and modest analgesia effects[1][2][3]. Medetomidine is an orally active α2-adrenoceptor agonist (Ki: 1.08 nM). Medetomidine has sedative and analgesic effects. Medetomidine can cause peripheral vasoconstriction through the activation of α2 adrenoceptors on blood vessels[1][2][3][4].
Harmalol
C12H12N2O (200.09495819999998)
Harmalol is found in fruits. Harmalol is an alkaloid from Passiflora incarnata (maypops). Harmaline is a reversible inhibitor of MAO-A (RIMA). Harmine is a reversible inhibitor of MAO-A (RIMA). It is important to note that unlike synthetic pharmaceutical MAOIs such as phenelzine, harmine is reversible and selective meaning it does not have nearly as high a risk for the "cheese syndrome" caused by consuming tyramine-containing foods, which is a risk associated with monoamine oxidase A inhibitors, but not monoamine oxidase B inhibitors. Several alkaloids that function as monoamine oxidase inhibitors (MAOIs) are found in the seeds of Peganum harmala (also known as Harmal or Syrian Rue), including harmine, harmaline, and harmalol, which are members of a group of substances with a similar chemical structure collectively known as harmala alkaloids. These alkaloids are of interest for their use in Amazonian shamanism, where they are derived from other plants. The harmala alkaloid harmine which was once known as Telepathine and Banisterine is a naturally occurring beta-carboline alkaloid that is structurally related to harmaline, and also found in the vine Banisteriopsis caapi. Tetrahydroharmine is also found in B. caapi, but not P. harmala. Dr. Alexander Shulgin has suggesed that harmaline may be a breakdown product of harmine. Harmine and harmaline are reversible MAOIs of the MAO-A isoform of the enzyme, and can stimulate the central nervous system by inhibiting the metabolism of monoamine compounds such as serotonin and norepinephrine. The harmala alkaloids occur in Peganum harmala in concentrations of roughly 3\\%, though tests have documented anywhere from 2-7\\%, as natural sources tend to vary widely in chemical makeup. Harmala alkaloids are also found in the Banisteriopsis caapi vine, the key plant ingredient in the sacramental beverage Ayahuasca, in concentrations that range between 0.31-8.43\\% for harmine, 0.03-0.83\\% for harmaline and 0.05-2.94\\% for tetrahydroharmine. Other psychoactive plants are often added to Ayahuasca to achieve visionary states of consciousness; for example leaves from Psychotria viridis, which is a source of dimethyltryptamine (DMT). The harmala alkaloids serve to potentiate these brewed compounds by preventing their breakdown in the digestive tract. The harmala alkaloids are not especially psychoactive on their own, even at high dosages, when vomiting and diarrhea become the main effect Alkaloid from Passiflora incarnata (maypops)
tetrahydrozoline
R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AB - Sympathomimetics, combinations excl. corticosteroids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AA - Sympathomimetics, plain S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics > S01GA - Sympathomimetics used as decongestants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D019999 - Pharmaceutical Solutions > D009883 - Ophthalmic Solutions D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents Tetrahydrozoline (Tetryzoline), a derivative of imidazoline, is an α-adrenergic agonist that causes vasoconstriction. Tetrahydrozoline is widely used for the research of nasal congestion and conjunctival congestion[1][2].
Dexmedetomidine
Dexmedetomidine is only found in individuals that have used or taken this drug. It is an agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine. [PubChem]Dexmedetomidine is a specific and selective alpha-2 adrenoceptor agonist. By binding to the presynaptic alpha-2 adrenoceptors, it inhibits the release if norepinephrine, therefore, terminate the propagation of pain signals. Activation of the postsynaptic alpha-2 adrenoceptors inhibits the sympathetic activity decreases blood pressure and heart rate. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives D002491 - Central Nervous System Agents > D000700 - Analgesics Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Dexmedetomidine ((+)-Medetomidine) is a potent, selective and orally active agonist of α2-adrenoceptor, with a Ki of 1.08 nM. Dexmedetomidine shows 1620-fold selectivity against α1-adrenoceptor. Dexmedetomidine exhibits anxiolysis, sedation, and modest analgesia effects[1][2][3]. Medetomidine is an orally active α2-adrenoceptor agonist (Ki: 1.08 nM). Medetomidine has sedative and analgesic effects. Medetomidine can cause peripheral vasoconstriction through the activation of α2 adrenoceptors on blood vessels[1][2][3][4].
(1R,2R,3S,1'R)-Nepetalinic acid
(1R,2R,3S,1S)-Nepetalinic acid is found in herbs and spices. (1R,2R,3S,1S)-Nepetalinic acid is a constituent of oil of catnip Constituent of oil of catnip. (1R,2R,3S,1R)-Nepetalinic acid is found in tea and herbs and spices.
Matsutakic acid A
Matsutakic acid A is found in mushrooms. Matsutakic acid A is isolated from the fungus Laetiporus sulphureus var. miniatus. Isolated from the fungus Laetiporus sulphureus variety miniatus. Matsutakic acid A is found in mushrooms.
(±)-Camphoric acid
(±)-Camphoric acid is found in tea. (±)-Camphoric acid is a constituent of red tea Constituent of red tea. (±)-Camphoric acid is found in tea.
(S)-9-Hydroxy-10-undecenoic acid
(S)-9-Hydroxy-10-undecenoic acid is found in green vegetables. (S)-9-Hydroxy-10-undecenoic acid is a constituent of Corchorus olitorius (Jews mallow)
cis-4-Decenedioic acid
cis-4-Decenedioic acid is a member of the class of compounds known as medium-chain fatty acids. Medium-chain fatty acids are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Thus, cis-4-decenedioic acid is considered to be a fatty acid lipid molecule. Cis-4-decenedioic acid is slightly soluble (in water) and a weakly acidic compound (based on its pKa). Cis-4-decenedioic acid can be found primarily in urine. Within the cell, cis-4-decenedioic acid is primarily located in the membrane. It can also be found in the extracellular space. Moreover, cis-4-decenedioic acid is an unsaturated dicarboxylic acid. Its level increases in patients with medium chain acyl-CoA dehydrogenase deficiency (MCADD), which is a genetic disorder of fatty acid oxidation. cis-4-Decenedioic acid is an unsaturated dicarboxylic acid. Its level increases in patients with medium chain acyl-CoA dehydrogenase deficiency, which is a disorder of fatty acid oxidation. [HMDB]
cis-5-Decenedioic acid
cis-5-Decenedioic acid is a mono-unsaturated dicarboxylic acid. The dicarboxylic acid can be grouped into two metabolic series: the cis-4 series as well as the cis-3 and cis-5 series. The metabolic precursor of cis-5 unsaturated dicarboxylic acid is oleic acid (PMID: 2380628). cis-5-Decenedioic acid is found to be associated with medium chain acyl-CoA dehydrogenase deficiency, which is an inborn error of metabolism. cis-5-Decenedioic acid is a mono-unsaturated dicarboxylic acid. The dicarboxylic acid can be grouped into two metabolic series: the cis-4 series as well as the cis-3 and cis-5 series. The metabolic precursor of cis-5 unsaturated dicarboxylic acid is oleic acid (PMID: 2380628). [HMDB]
5-Pentyltetrahydro-2-oxo-3-furancarboxylic acid
5-Pentyltetrahydro-2-oxo-3-furancarboxylic acid is found in milk and milk products. 5-Pentyltetrahydro-2-oxo-3-furancarboxylic acid is a possible latent butter aroma compoun
alpha-Carboxy-delta-nonalactone
alpha-Carboxy-delta-nonalactone is found in milk and milk products. alpha-Carboxy-delta-nonalactone is a possible latent butter aroma compoun
2-(2-Methylpropoxy)naphthalene
2-(2-Methylpropoxy)naphthalene is a flavouring ingredien Flavouring ingredient
Clarycet
Clarycet is a fragrance ingredient with a fruity arom Fragrance ingredient with a fruity aroma
3-Nonanon-1-yl acetate
3-Nonanon-1-yl acetate is a flavouring ingredient. Removed from the GRAS (Generally Recognized As Safe) list (formerly *FEMA 2566*). Flavouring ingredient [DFC]
Hydralazine acetone hydrazone
Hydralazine acetone hydrazone is a metabolite of hydralazine. Hydralazine (apresoline) is a direct-acting smooth muscle relaxant used to treat hypertension by acting as a vasodilator primarily in arteries and arterioles. By relaxing vascular smooth muscle, vasodilators act to decrease peripheral resistance, thereby lowering blood pressure and decreasing afterload. (Wikipedia)
Ecgoninium Methyl Ester(1+)
Ecgoninium Methyl Ester(1+) is also known as Ecgonine methyl ester or Ecgonine methyl ester, (1R-(endo,endo))-isomer. Ecgoninium Methyl Ester(1+) is considered to be slightly soluble (in water) and relatively neutral
levomedetomidine
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics Medetomidine is an orally active α2-adrenoceptor agonist (Ki: 1.08 nM). Medetomidine has sedative and analgesic effects. Medetomidine can cause peripheral vasoconstriction through the activation of α2 adrenoceptors on blood vessels[1][2][3][4].
1-Pyrrolidinyloxy, 3-(methoxycarbonyl)-2,2,5,5-tetramethyl-
2-Hydroxycampholonic acid
2-hydroxycampholonic acid belongs to iridoids and derivatives class of compounds. Those are monoterpenes containing a skeleton structurally characterized by the presence of a cylopentane fused to a pyran ( forming a 4,7-dimethylcyclopenta[c]pyran), or a derivative where the pentane moiety is open. 2-hydroxycampholonic acid is soluble (in water) and a weakly acidic compound (based on its pKa). 2-hydroxycampholonic acid can be found in common sage, which makes 2-hydroxycampholonic acid a potential biomarker for the consumption of this food product.
N-alpha-acetyl lysine methyl ester
C9H16N2O3 (200.11608660000002)
N-alpha-acetyl lysine methyl ester is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). N-alpha-acetyl lysine methyl ester can be found in a number of food items such as sesbania flower, rambutan, cloud ear fungus, and banana, which makes N-alpha-acetyl lysine methyl ester a potential biomarker for the consumption of these food products.
(3R,3aS,4R,5S,6aS)-Hexahydro-3,4-bis(hydroxymethyl)-5-methyl-2H-cyclopenta[b]furan-2-one
Dehydrochamecynenal
[4S-(4alpha,5alpha,6beta)]-4,6-dihydroxy-2-(hydroxymethyl)-5-(1-methylethyl)-2-Cyclohexen-1-one
N-hydroxy-2-naphthalen-1-ylethanimidamide
C12H12N2O (200.09495819999998)
Harmolol
C12H12N2O (200.09495819999998)
A harmala alkaloid in which the harman skeleton is hydroxy-substituted at C-7 and has been reduced across the 3,4 bond. relative retention time with respect to 9-anthracene Carboxylic Acid is 0.398 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.395 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.387 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.386
(4S,5R,7S,8S,9S)-7,8-dihydroxydihyronepetalactone|jatamanin G
4-hydroxy-10-methyl-oxecane-2,6-dione|Diplodiadid-D|Diplodialide D
(Z)-2-Methyl-2-buttersaeure-(2-hydroperoxy-2-methyl-3-butenyl)ester
5-Hydroxy-3-(1-hydroxy-2-methylbutyl)-4-methyl-2(5H)-furanone
8,9-Dihydro-6H-pyrido[2,1-b]quinazolin-11(7H)-one
C12H12N2O (200.09495819999998)
(Z)-2-Methyl-2-butensaeure-(3-hydroperoxy-2-methylidenbutyl)ester
cis-Tetradecen-(5)-triin-(8.10.12)-ol-(1)|tetradec-5c-ene-8,10,12-triyn-1-ol
3,7-dimethyl-1-hydroxy-7-peroxy-octa-2E,5E-dien-4-one|7-Hydroperoxide-(2E,5E)-1,7-Dihydroxy-3,7-dimethyl-2,5-octadien-4-one
(2E)-6-hydroxy-2-hydroxymethyl-6-methyl-2,7-octadienoic acid
(E,E,E)-form-4,6,12-Tetradecatriene-8,10-diyn-1-ol,|4,6,12-Tetradecatriene-8,10-diyn-1-ol,|all-trans-1-Hydroxy-tetradecatrien-(4.6.12)-diin-(8.10)|all-trans-Tetradeca-4,6,12-trien-8,10-diin-1-ol|Tetradeca-4,6,12-trien-8,10-diin-1-ol|tetradeca-4,6,12-trien-8,10-diyn-1-ol|Tetradeca-4t,6t,12t-trien-8,10-diin-1-ol|tetradeca-4t,6t,12t-triene-8,10-diyn-1-ol
3-Hydroxy-2,8-dimethyl-1,7-dioxaspiro[5.5]undecane
methyl 2,3-dihydrogeraniol-8-oate|methyl 8-hydroxy-2,6-dimethyl-2-(E)-octenoate
tetradec-6t-ene-8,10,12-triyn-3-ol|Tetradecatriin-(8.10.12)-en-(6)-ol-(3)|Tetradecen-(6)-triin-(8.10.12)-ol-(3)|trans-Tetradecen-(8)-triin-(2.4.6)-ol-(12)
(4R,4aR,6S,7S,7aS)-6-hydroxy-7-hydroxymethyl-4-methylperhydrocyclopenta[c]pyran-1-one|(4R,5R,7S,8S,9S)-7-Hydroxy-8-hydroxymethyl-4-methyl-perhydrocyclopenta[c]pyran-1-one
Camphoric_acid
(-)-Camphoric acid is the less active enantiomer of Camphoric acid. Camphoric acid stimulates osteoblast differentiation and induces glutamate receptor expression. Camphoric acid also significantly induced the activation of NF-κB and AP-1[1]. (-)-Camphoric acid is the less active enantiomer of Camphoric acid. Camphoric acid stimulates osteoblast differentiation and induces glutamate receptor expression. Camphoric acid also significantly induced the activation of NF-κB and AP-1[1]. (-)-Camphoric acid is the less active enantiomer of Camphoric acid. Camphoric acid stimulates osteoblast differentiation and induces glutamate receptor expression. Camphoric acid also significantly induced the activation of NF-κB and AP-1[1]. (-)-Camphoric acid is the less active enantiomer of Camphoric acid. Camphoric acid stimulates osteoblast differentiation and induces glutamate receptor expression. Camphoric acid also significantly induced the activation of NF-κB and AP-1[1]. (-)-Camphoric acid is the less active enantiomer of Camphoric acid. Camphoric acid stimulates osteoblast differentiation and induces glutamate receptor expression. Camphoric acid also significantly induced the activation of NF-κB and AP-1[1]. (-)-Camphoric acid is the less active enantiomer of Camphoric acid. Camphoric acid stimulates osteoblast differentiation and induces glutamate receptor expression. Camphoric acid also significantly induced the activation of NF-κB and AP-1[1].
Gelsemiol
Gelsemiol is a natural product found in Gelsemium sempervirens, Gelsemium elegans, and Verbena litoralis with data available.
Silane, (6-ethoxy-3,4-dihydro-2H-pyran-5-yl)trimethyl- (9CI)
C10H20O2Si (200.12325000000004)
1H-Benzimidazole,1-ethenyl-2-[(ethenyloxy)methyl]-(9CI)
C12H12N2O (200.09495819999998)
ACETAMIDE, N-(4-AMINO-1-NAPHTHYL)-
C12H12N2O (200.09495819999998)
ethyl (E)-3-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]prop-2-enoate
(Z)-7-[(1R,2R,3R,5S)-5-ACETOXY-3-HYDROXY-2-((E)-(S)-3-HYDROXY-OCT-1-ENYL)-CYCLOPENTYL]-HEPT-5-ENOICACIDMETHYLESTER
(2R)-2-cyclopropyl-2-[[(1R)-1-phenylethyl]amino]acetonitrile
2-Piperazineaceticacid,4-ethyl-3-oxo-,methylester(9CI)
C9H16N2O3 (200.11608660000002)
Pyrido[1,2-a]benzimidazole, 1,2,3,4-tetrahydro-3,3-dimethyl- (9CI)
2-PHENYL-4,5,6,7-TETRAHYDROOXAZOLO[5,4-C]PYRIDINE
C12H12N2O (200.09495819999998)
2-(3-METHYLPIPERIDIN-1-YL)PROPAN-1-OL
C9H16N2O3 (200.11608660000002)
N,N-dimethylpiperazine-1,4-dicarboxamide
C8H16N4O2 (200.12731960000002)
(1S,3R)-3-(Ethoxycarbonyl)cyclohexanecarboxylic acid
(1R,4R)-4-(ETHOXYCARBONYL)CYCLOHEXANECARBOXYLIC ACID
1-(4-AMINO-2-FLUOROPHENYL)ETHANONE
C12H12N2O (200.09495819999998)
1H-Benzimidazole,1-(5,6-dihydro-2H-pyran-2-yl)-,(S)-(9CI)
C12H12N2O (200.09495819999998)
1-(4-(4-Methyl-1H-imidazol-1-yl)phenyl)ethanone
C12H12N2O (200.09495819999998)
4-PYRIDIN-3-YL-4,5,6,7-TETRAHYDRO-3H-IMIDAZO[4,5-C]PYRIDINE
1-ethyl-2,3-dimethylimidazol-3-ium,methyl carbonate
C9H16N2O3 (200.11608660000002)
Benzenamine, 4-(6-methoxy-3-pyridinyl)- (9CI)
C12H12N2O (200.09495819999998)
(1E,3Z)-1-methoxy-2-methyl-3-[(trimethylsilyl)oxy]-penta-1,3-diene
C10H20O2Si (200.12325000000004)
4-(4-METHYL-PIPERAZIN-1-YL)-4-OXO-BUTYRIC ACID
C9H16N2O3 (200.11608660000002)
2-[(1-METHYL-3-OXO-3-PHENYL-1-PROPENYL)AMINO]ACETONITRILE
C12H12N2O (200.09495819999998)
(1R,2R)-DIMETHYL CYCLOHEXANE-1,2-DICARBOXYLATE
2-(1-METHYL-1H-IMIDAZOL-2-YL)-1-PHENYLETHANONE
C12H12N2O (200.09495819999998)
1H-Benzimidazole,2-(1-methylethyl)-1-(2-propenyl)-(9CI)
3-(4-HYDROXY-CYCLOHEXYL)-PROPIONIC ACID ETHYL ESTER
1-[(dimethylamino)carbonyl]piperidine-4-carboxylic acid
C9H16N2O3 (200.11608660000002)
1-[(dimethylamino)carbonyl]piperidine-3-carboxylic acid
C9H16N2O3 (200.11608660000002)
1,4-Benzenediamine,N1,N1-diethyl-, hydrochloride (1:1)
2-Methyl-2-propanyl 2-oxo-1-piperazinecarboxylate
C9H16N2O3 (200.11608660000002)
2H-Pyran-3-carboxylicacid,tetrahydro-6,6-dimethyl-4-oxo-,ethylester(9CI)
3-HYDROXYMETHYL-PIPERAZINE-1-CARBOXYLIC ACID ALLYL ESTER
C9H16N2O3 (200.11608660000002)
Benzenamine, 4-(2,5-dimethyl-1H-pyrrol-1-yl)-3-methyl- (9CI)
(R,E)-ETHYL 3-(2,2-DIMETHYL-1,3-DIOXOLAN-4-YL)ACRYLATE
(2,2-dimethyl-1,3-dioxolan-4-yl)methyl methacrylate
Cyclopentanemethanol, 2-[(tetrahydro-2H-pyran-2-yl)oxy]- (9CI)
(5-Ethoxy-1H-indol-3-yl)acetonitrile
C12H12N2O (200.09495819999998)
4-METHOXY-NAPHTHALENE-1-CARBOXAMIDINE
C12H12N2O (200.09495819999998)
n-Butyl 2,2,2-trifluoroethylacetaldehyde acetal
C8H15F3O2 (200.10240860000002)
2-BENZOYL-3-(DIMETHYLAMINO)ACRYLONITRILE
C12H12N2O (200.09495819999998)
2-(5-METHOXY-PYRIDIN-2-YL)-PHENYLAMINE
C12H12N2O (200.09495819999998)
3-Oxo-3-(tetrahydro-pyran-4-yl)-propionic acid ethyl ester
2-Methoxy-1-naphthalenecarboximidamide
C12H12N2O (200.09495819999998)
METHYL 2-(3-METHYL-2-OXO-PIPERAZIN-1-YL)PROPIONATE
C9H16N2O3 (200.11608660000002)
C-(6,7,8,9-TETRAHYDRO-5 H-CARBAZOL-3-YL)-METHYLAMINE
TERT-BUTYL 5-OXOPYRROLIDIN-3-YLCARBAMATE
C9H16N2O3 (200.11608660000002)
(5S)-5,6-DIHYDRO-5,6-DIHYDROXY-6-METHYLHEPTAN-2-ONE ACETONIDE
Ethyl 4-carbamimidoylpiperazine-1-carboxylate
C8H16N4O2 (200.12731960000002)
3-Trimethylsilylpropargyl aldehyde diethyl acetal
C10H20O2Si (200.12325000000004)
[(Z)-(1,3-dihydroxy-2,2,5,5-tetramethylimidazolidin-4-ylidene)methyl]diazene
C8H16N4O2 (200.12731960000002)
4-HYDROXY-CYCLOHEXANECARBOXYLIC ACID METHYL ESTER ACETATE
Pyrido[1,2-a]benzimidazole, 1,2,3,4-tetrahydro-4,9-dimethyl- (9CI)
Cyclohexanecarbothioicacid, S-(1,1-dimethylethyl) ester
1H-Benzimidazole,2-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-(9CI)
1-(2-DIMETHYLAMINO-ETHYL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID
C9H16N2O3 (200.11608660000002)
tert-butyl N-(2-oxopyrrolidin-3-yl)carbamate
C9H16N2O3 (200.11608660000002)
1H-1,2,4-Triazole-1-aceticacid,4-amino-3-ethyl-4,5-dihydro-5-oxo-,hydrazide(9CI)
C6H12N6O2 (200.10216920000002)
TERT-BUTYL 3-(HYDROXYIMINO)PYRROLIDINE-1-CARBOXYLATE
C9H16N2O3 (200.11608660000002)
tert-Butyl 2-(cyclopropanecarbonyl)hydrazinecarboxylate
C9H16N2O3 (200.11608660000002)
2-Ethyl-1-(2-methyl-2-propen-1-yl)-1H-benzimidazole
2-Methyl-2-propanyl 3-oxo-1-piperazinecarboxylate
C9H16N2O3 (200.11608660000002)
(2S)-(1-Tetrahydropyramid-2-one)-3-methylbutanoic acid
C9H16N2O3 (200.11608660000002)
Thiourea, N-cyclopentyl-N-(1,1-dimethylethyl)- (9CI)
trans-2-butene-1,4-dicarboxylic acid diethyl ester
1-ethyl-3-methylimidazolium DL-lactate
C9H16N2O3 (200.11608660000002)
2-(dimethoxymethylsilyl)-bicyclo[2,2,1]heptanes
C10H20O2Si (200.12325000000004)
Pyrido[1,2-a]benzimidazole, 1,2,3,4-tetrahydro-2,2-dimethyl- (9CI)
1H-Benzimidazole,5,6-dimethyl-1-(2-methyl-2-propenyl)-(9CI)
7-(1,2,4-triazol-4-yl)-1,2,3,4-tetrahydroisoquinoline
(t-Butyldimethylsilyloxy)cyclopropanecarbaldehyde
C10H20O2Si (200.12325000000004)
ALLYL 3-AMINO-3-(HYDROXYMETHYL)PYRROLIDINE-1-CARBOXYLATE
C9H16N2O3 (200.11608660000002)
(z)-ethyl-4,5-o-isopropylidene-(s)-4,5-dihydroxy-2-pentenoate
2,8-Dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
5-(2-DIETHYLAMINO-ETHYL)-[1,3,4]THIADIAZOL-2-YLAMINE
tert-butyl(4s)-1-methyl-2-oxoimidazolidine-4-carboxylate
C9H16N2O3 (200.11608660000002)
N-Methyl-4-(dimethylamino)benzylamine Hydrochloride
1-(dimethylcarbamoyl)piperidine-2-carboxylic acid
C9H16N2O3 (200.11608660000002)
N-[(Cyclohexylamino)carbonyl]glycine
C9H16N2O3 (200.11608660000002)
COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
LevoMedetoMidine
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
2,5-Dimethyl-1,2,3,4-tetrahydropyrimido(3,4-a)indole
Trimethylsilyl cyclohexanecarboxylate
C10H20O2Si (200.12325000000004)
PYRIMIDO(3,4-a)INDOLE, 1,2,3,4-TETRAHYDRO-5,7-DIMETHYL-
N-alpha-acetyl lysine methyl ester
C9H16N2O3 (200.11608660000002)
N-alpha-acetyl lysine methyl ester is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). N-alpha-acetyl lysine methyl ester can be found in a number of food items such as sesbania flower, rambutan, cloud ear fungus, and banana, which makes N-alpha-acetyl lysine methyl ester a potential biomarker for the consumption of these food products. N-α-acetyl lysine methyl ester is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). N-α-acetyl lysine methyl ester can be found in a number of food items such as sesbania flower, rambutan, cloud ear fungus, and banana, which makes N-α-acetyl lysine methyl ester a potential biomarker for the consumption of these food products.
Methyl ecgonine
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
4-(1-methyl-2-pyrrolidinyl)-3-oxobutanoate methyl ester
6-methyl-2,3,4,5-tetrahydro-1H-azepino[4,5-b]indole
Lactinolide
A monoterpenoid that is hexahydro-1-benzofuran-2-one carrying two methyl substituents at positions 3 and 6 as well as two hydroxy substituents at positions 5 and 6 (the 3R,3aR,5S,6S,7aR-diastereomer).
3-[(2-Aminoethyl)thio]-6-methyl-1-azabicyclo[3.2.0]heptan-7-one
(2E,10R)-10-hydroxyundec-2-enoic acid
An (omega-1)-hydroxy fatty acid that is trans-undec-2-enoic acid in which the 10-pro-R hydrogen is replaced by a hydroxy group.
(Z)-1,4-Bistrimethylsilyl-2-butene
C10H24Si2 (200.14164639999998)
2-Heptenoic acid,trimethylsilyl ester
C10H20O2Si (200.12325000000004)
Cyclopentylacetic acid trimethylsilyl ester
C10H20O2Si (200.12325000000004)
tetrahydrozoline
R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AB - Sympathomimetics, combinations excl. corticosteroids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AA - Sympathomimetics, plain S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics > S01GA - Sympathomimetics used as decongestants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D019999 - Pharmaceutical Solutions > D009883 - Ophthalmic Solutions D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents Tetrahydrozoline (Tetryzoline), a derivative of imidazoline, is an α-adrenergic agonist that causes vasoconstriction. Tetrahydrozoline is widely used for the research of nasal congestion and conjunctival congestion[1][2].
Dexmedetomidine
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives D002491 - Central Nervous System Agents > D000700 - Analgesics Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Dexmedetomidine ((+)-Medetomidine) is a potent, selective and orally active agonist of α2-adrenoceptor, with a Ki of 1.08 nM. Dexmedetomidine shows 1620-fold selectivity against α1-adrenoceptor. Dexmedetomidine exhibits anxiolysis, sedation, and modest analgesia effects[1][2][3].
sebacate(2-)
A dicarboxylic acid dianion obtained by deprotonation of both carboxy groups of suberic acid; major species at pH 7.3.
N-octanoylglycinate
An N-acylglycinate resulting from the deprotonation of the carboxy group of N-octanoylglycine. The conjugate base of N-octanoylglycine; major species at pH 7.3.
(2E)-11-hydroxyundec-2-enoic acid
An omega-hydroxy fatty acid that is trans-undec-2-enoic acid in which one of the hydrogens attached to the terminal methyl group is replaced by a hydroxy group.
Ecgoninium Methyl Ester(1+)
The conjugate acid of ecgonine methyl ester arising from protonation of the tertiary amino group; major species at pH 7.3.
1-isopropyl-4-methoxy-4-methylbicyclo[3.1.0]hexane-2,3-diol
(1s)-1-[(2s,3ar,6r,6as)-6-(hydroxymethyl)-hexahydro-2h-cyclopenta[b]furan-2-yl]propan-1-ol
6-[(1s)-1-hydroxypropyl]-4-methoxy-5-methyl-2h-pyran-2-ol
3-hydroperoxy-2-methylidenebutyl 2-methylbut-2-enoate
6,7-dihydroxy-4,7-dimethyl-hexahydrocyclopenta[b]pyran-3-one
3,4-bis(hydroxymethyl)-5-methyl-hexahydrocyclopenta[b]furan-2-one
(4r,4ar,6s,7r,7as)-6,7-dihydroxy-4,7-dimethyl-hexahydrocyclopenta[b]pyran-3-one
(4s,4ar,6s,7r,7ar)-6-hydroxy-4-(hydroxymethyl)-7-methyl-hexahydro-1h-cyclopenta[c]pyran-3-one
7-hydroperoxy-1-hydroxy-3,7-dimethylocta-2,5-dien-4-one
(3s,6s)-3-[(1r)-1-hydroxyethyl]-6-isopropyl-3,6-dihydropyrazine-2,5-diol
C9H16N2O3 (200.11608660000002)
5,8-dihydroxy-10-methyl-3,4,5,8,9,10-hexahydrooxecin-2-one
4,7-dihydroxy-10-methyl-3,4,7,8,9,10-hexahydro-oxecin-2-one
{"Ingredient_id": "HBIN010089","Ingredient_name": "4,7-dihydroxy-10-methyl-3,4,7,8,9,10-hexahydro-oxecin-2-one","Alias": "NA","Ingredient_formula": "C10H16O4","Ingredient_Smile": "CC1CCC(C=CC(CC(=O)O1)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6033","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(4r,5r,7s,8s,9s)-7-hydroxy-8-hydroxymethyl-4-methyl-perhydrocyclopenta[ c]pyran-1-one
{"Ingredient_id": "HBIN010867","Ingredient_name": "(4r,5r,7s,8s,9s)-7-hydroxy-8-hydroxymethyl-4-methyl-perhydrocyclopenta[ c]pyran-1-one","Alias": "NA","Ingredient_formula": "C10H16O4","Ingredient_Smile": "CC1COC(=O)C2C1CC(C2CO)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10207","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7-(prop-1-en-2-yl)-5,6,7,8-tetrahydronaphthalene-1-carbaldehyde
(5r,6r,8r)-6-hydroxy-8-(hydroxymethyl)-2-oxaspiro[4.5]decan-1-one
methyl (1s,2r,3s,5r)-3-hydroxy-2-methyl-5-(2-oxoethyl)cyclopentane-1-carboxylate
(7e)-4,7-dihydroxy-10-methyl-3,4,5,6,9,10-hexahydrooxecin-2-one
6-hydroxy-2-(hydroxymethyl)-6-methylocta-2,7-dienoic acid
4-(1-hydroxybut-3-en-2-yl)-3-(hydroxymethyl)oxan-2-one
(3s,6s)-3-[(2s)-butan-2-yl]-6-(hydroxymethyl)-3,6-dihydropyrazine-2,5-diol
C9H16N2O3 (200.11608660000002)